The effects of prior use of atorvastatin on coronary blood flow after primary percutaneous coronary intervention in patients presenting with acute myocardial infarction

被引:27
作者
Celik, T [1 ]
Kursaklioglu, H
Iyisoy, A
Kose, S
Kilic, S
Amasyali, B
Kardesoglu, E
Isik, E
机构
[1] Gulhane Mil Med Acad, Gulhane Sch Med, Dept Cardiol, TR-06018 Ankara, Turkey
[2] Gulhane Mil Med Acad, Dept Epidemiol, TR-06018 Ankara, Turkey
[3] Haydarpasa Training Hosp, Gulhane Mil Med Acad, Dept Cardiol, Istanbul, Turkey
关键词
statin; atorvastatin; primary angioplasty; acute myocardial infarction; Thrombolysis In Myocardial Infarction frame count method;
D O I
10.1097/00019501-200508000-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Statins exert a variety of favourable effects on the vascular system not directly related to their lipid lowering function known as pleiotropic effects. There are not enough data regarding the effects of prior statin use on coronary blood flow after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI). Accordingly, in the present study, we aimed to investigate the effects of prior statin use on coronary blood flow after primary PCI in patients with AMI using the Thrombolysis In Myocardial Infarction (TIMI) frame count method. Methods The study population consisted of 200 patients (161 men; mean age = 62 +/- 7 years) referred to cardiology clinics with AMI who subsequently underwent successful primary PCI. The study population was divided into two groups according to statin use before primary PCI. Group 1 consisted of 98 patients (75 men; mean age = 63 +/- 7 years) not taking statin and group 2 consisted of 102 patients (86 men; mean age = 61 +/- 7 years) taking daily dose of at least 40 mg atorvastatin for at least 6 months. Coronary blood flow was determined by TIMI frame count method using the angiographic images obtained just after PCI and stenting. Results Only mean TIMI frame count was detected to be significantly lower in patients taking at least 40 mg atorvastatin for at least 6 months compared with that of the patients taking no statin (P < 0.001). After confounding variables were controlled for, the mean TIMI frame count of patients in group 2 was significantly lower than that of the patients in group 1 (P=0.001). Pain to balloon time and vessel type were detected as important confounding variables of TIMI frame count after analysis of covariances. Conclusions Prior statin use may improve coronary blood flow after PCI in patients with AMI, possibly by its beneficial effects on microvascular function.
引用
收藏
页码:321 / 326
页数:6
相关论文
共 32 条
[1]   Beyond lipids - the role of the endothelium in coronary artery disease [J].
Aengevaeren, WR .
ATHEROSCLEROSIS, 1999, 147 :S11-S16
[2]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[3]   Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway [J].
Bell, RM ;
Yellon, DM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (03) :508-515
[4]   Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering [J].
Bonetti, PO ;
Wilson, SH ;
Rodriguez-Porcel, M ;
Holmes, DR ;
Lerman, LO ;
Lerman, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (03) :546-554
[5]  
Campeau L, 1997, NEW ENGL J MED, V336, P153
[6]   Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction - Importance of microvascular reperfusion injury on clinical outcome [J].
Claeys, MJ ;
Bosmans, J ;
Veenstra, L ;
Jorens, P ;
De Raedt, H ;
Vrints, CJ .
CIRCULATION, 1999, 99 (15) :1972-1977
[7]   Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts [J].
Di Napoli, P ;
Taccardi, AA ;
Grilli, A ;
Spina, R ;
Felaco, M ;
Barsotti, A ;
De Caterina, R .
CARDIOVASCULAR RESEARCH, 2001, 51 (02) :283-293
[8]   Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase [J].
Endres, M ;
Laufs, U ;
Huang, ZH ;
Nakamura, T ;
Huang, P ;
Moskowitz, MA ;
Liao, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8880-8885
[9]   INSULIN-LIKE GROWTH-FACTORS AND NEONATAL CARDIOMYOCYTE DEVELOPMENT - VENTRICULAR GENE-EXPRESSION AND MEMBRANE-RECEPTOR VARIATIONS IN NORMOTENSIVE AND HYPERTENSIVE RATS [J].
ENGELMANN, GL ;
BOEHM, KD ;
HASKELL, JF ;
KHAIRALLAH, PA ;
ILAN, J .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1989, 63 (1-2) :1-14
[10]   HEMODYNAMIC PRINCIPLES IN THE CONTROL OF CORONARY BLOOD-FLOW [J].
EPSTEIN, SE ;
CANNON, RO ;
TALBOT, TL .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 56 (09) :E4-E10